MediPharm Labs (MEDIF) Stock Forecast & Price Target
MEDIF Analyst Ratings
There are no analyst ratings in the last 3 months.
MEDIF Stock 12 Month Forecast
There are no analyst price targets in the last 3 months.
Detailed List of Analyst Forecasts
| Analyst Profile | Expert Firm | Price Target | Position | Upside / Downside | Action | Date | Follow | Article |
|---|---|---|---|---|---|---|---|---|
| PerPlexity - SonarReasoningPro | TipRanks - PerPlexity | $0.05→$0.04 | hold | -10.83%Downside | Reiterated | 10/27/26 | ||
| Google Drug Manufacturers - Specialty and Generic | TipRanks - Google | $0.05→$0.05 | hold | -4.88%Downside | Downgraded | 10/27/26 | ||
| Anthropic Drug Manufacturers - Specialty and Generic | TipRanks - Anthropic | $0.05→$0.04 | hold | -12.31%Downside | Reiterated | 10/27/26 | ||
| OpenAI - Gpt-5.6Sol | TipRanks - OpenAI | $0.05→$0.04 | hold | -10.83%Downside | Reiterated | 10/27/26 | ||
| DeepSeek - V4Pro | TipRanks - DeepSeek | $0.05→$0.04 | hold | -7.86%Downside | Reiterated | 10/27/26 | ||
| xAI - Grok-4.3 | TipRanks - xAI | $0.05→$0.04 | hold | -9.34%Downside | Reiterated | 10/27/26 |
| Analyst Profile | Date | Price Target | Position | Upside / Downside | Action | Follow | Article | Expert Firm |
|---|---|---|---|---|---|---|---|---|
| PerPlexity - SonarReasoningPro | 10/27/26 | $0.05→$0.04 | hold | -10.83%Downside | Reiterated | TipRanks - PerPlexity | ||
| Google Drug Manufacturers - Specialty and Generic | 10/27/26 | $0.05→$0.05 | hold | -4.88%Downside | Downgraded | TipRanks - Google | ||
| Anthropic Drug Manufacturers - Specialty and Generic | 10/27/26 | $0.05→$0.04 | hold | -12.31%Downside | Reiterated | TipRanks - Anthropic | ||
| OpenAI - Gpt-5.6Sol | 10/27/26 | $0.05→$0.04 | hold | -10.83%Downside | Reiterated | TipRanks - OpenAI | ||
| DeepSeek - V4Pro | 10/27/26 | $0.05→$0.04 | hold | -7.86%Downside | Reiterated | TipRanks - DeepSeek | ||
| xAI - Grok-4.3 | 10/27/26 | $0.05→$0.04 | hold | -9.34%Downside | Reiterated | TipRanks - xAI |
MEDIF Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 0 | 0 | 0 | 0 | 0 |
In the current month, MEDIF has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. MEDIF average Analyst price target in the past 3 months is ―.
MEDIF Financial Forecast
MEDIF Earnings Forecast
Next quarter’s earnings estimate for MEDIF is $0.00 with a range of $0.00 to $0.00. The previous quarter’s EPS was $0.00. MEDIF beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year MEDIF has Performed in-line its overall industry.
MEDIF Sales Forecast
Next quarter’s sales forecast for MEDIF is $7.28M with a range of $7.28M to $7.28M. The previous quarter’s sales results were $7.14M. MEDIF beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year MEDIF has Performed in-line its overall industry.